GL1X · GenesisL1 explorer

MolNFT v1 · #118373 · protein

Crystal structure of the N-terminal domain of vaccinia virus immunomodulator A46 in complex with myristic acid.

5EZU · Protein A46: “Crystal structure of the N-terminal domain of vaccinia virus immunomodulator A46 in complex with myristic…”. X-ray diffraction, 1 ligand (MYR), 1 pocket (best druggability 0.79). MolNFT v1 #118373 on GenesisL1: 3D…

PDB
5EZU
Type
protein
Length
143 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein A46
UniProt
P26672
Ligands
MYR
Pockets
1 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 0% helix, 67% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein A46protein760% helix, 66% strandP26672
BProtein A46protein670% helix, 69% strandP26672

Ligands and binding sites

  • MYR · Myristic acid · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11810.790.9324MYR

Interfaces

1 interface between chains.

  • A–B · 1348 Ų buried · 36 hydrogen bonds · protein-protein

Compared structures

  • 5EZU · Crystal structure of the N-terminal domain of vaccinia virus immunomodulator A46 in… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.